SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 71.50.
| Share Price | ₹1,162.7 | Sep 23,2026 |
| Market Cap | ₹2,581.1 Cr | |
| Earnings-TTM | ₹36.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 71.50x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,581.1 Cr] as on Sep 23,2026
(/) Earnings [ ₹36.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 71.50x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 71.50 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.38x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 26.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2022 of 15.24x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SAKAR HEALTHCARE | 36.10 | 71.50 | 2,581.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.76 | 447,476.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 87.10 | 254,764.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 87.86 | 189,423.0 |
| CIPLA LTD | 3,364.84 | 33.13 | 111,484.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.87 | 101,005.0 |
| MANKIND PHARMA LTD | 2,055.11 | 49.49 | 101,712.0 |
| LUPIN LTD | 5,551.01 | 17.30 | 96,030.9 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.97 | 116,658.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.73 | 99,252.7 |
| LAURUS LABS LTD | 1,090.76 | 100.79 | 109,943.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.30x |
| Max industry PE | 100.79x |
| Median industry PE | 36.76x |
| Average industry PE | 51.68x |
You may also like the below Video Courses